FindTrial
Sign In

Correlation of urinary porphyrin and biochemical markers with the severity of symptoms of COVID-19 cases.

Correlation of urinary porphyrin and biochemical markers with the severity of symptoms of COVID-19 cases.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/026250
Enrollment
100
Registered
2020-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

DR JYOTIRMAYEE BAHINIPATI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic RT PCR positive COVID-19 Cases

Exclusion criteria

Exclusion criteria: RT PCR POSITIVE COVID-19 CASES WITH HISTORY OF PORPHYRIA, HEMOGLOBINOPATHIES. PREGNANT WOMEN THOSE WHO UNDERGO RECENT SURGERY

Design outcomes

Primary

MeasureTime frame
Cured or deathTimepoint: 3 months—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDR JYOTIRMAYEE BAHINIPATI

KIMS, KIIT University

jyotirmayee.bahinipati@kims.ac.in9437143193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026